

The Vox Markets Podcast
Vox Markets Podcast
Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.
Episodes
Mentioned books

Apr 9, 2026 • 9min
2362: Rome Resources wraps up drilling, assays next
Rome Resources has completed its latest round of drilling at the Kalayi prospect in the Democratic Republic of Congo. The company drilled just over 3,000 metres, and early results from XRF surveys look good, although these need to be confirmed by assays. The next step will be to put out an updated resource for Kalayi, expected around the end of May or early June. Rome's chief executive Paul Barrett joins Vox to tell us more

Apr 9, 2026 • 9min
2361: EGT Wind Power Pipeline Tops £100m
Watch on YouTubeEuropean Green Transition has released a quarterly update centred around the wind power business it bought recently. The company is seeing substantial business volumes and significant opportunities for growth in re-powering, and looks set to hit the revenue and EBITDA targets that it has previously released. Jack Kelly, EGT's CFO, and Fave Broadbent, managing director of the wind services business, join us to give a detailed breakdown of the numbers

Apr 7, 2026 • 14min
2360: 88 Energy: Is This the Breakthrough Moment?
Watch on YouTube88 Energy outlines its latest progress and upcoming catalysts, positioning the company for a potentially transformational period. With key milestones ahead, this interview explores why management believes momentum is building and what could drive the next phase of growth for investors.------------------------------------------------------------Follow us:X (Twitter): https://x.com/VOXmarketsLinkedIn: https://www.linkedin.com/company/vox-markets/TikTok: https://www.tiktok.com/@voxmarketsListen to our podcast:Apple Podcasts: https://podcasts.apple.com/gb/podcast/the-vox-markets-podcast/id1569138869Spotify: https://open.spotify.com/show/1noGnZw4hFfNgspb4puAlXLearn more: https://www.voxmarkets.com------------------------------------------------------------

Apr 7, 2026 • 7min
2359: MedPal AI record £5m Run-Rate — Can AI Pharmacy Deliver Profits?
Watch on YouTubeMedPal AI delivered explosive pharmacy growth in March, hitting 41,600 dispensed items and a £5 million annualised revenue run-rate with strong gross margins, driven by NHS services and private GLP-1 demand. Sophisticated investors will focus on whether this scaling can convert into sustainable group-level profitability amid regulatory risks and competitive pressures in the UK digital health market

Apr 2, 2026 • 15min
2358: Tungsten to $1 million/t?
The tungsten price has been roaring away lately, and has recently hit $300,000/t. It's the perfect time to be bringing tungsten projects on stream, and Pure Tungsten has not one but two projects on the go. The first, in South Korea, should be up and running by the summer, while the second, in Tajikistan will be producing within a year. These projects will then scale up, to the point where Pure Tungsten could well end up challenging established players like Almonty. The mines are big, the grade is good, and the price is right. Pure Tungsten executive director Jeremy Gray joins Vox to tell us more.Pre-IPO Investment Opportunity: https://www.puretungsten.ca/puretungsten-equity-raise-rn?SQF_LEAD_SOURCE=vx

Apr 2, 2026 • 18min
2357: Tharisa intiates 60-year underground mining plan
Tharisa has begun underground operations at its South African platinum group metals and chrome mine. The first underground blast took place this week, and development is now underway. The company already has a well established track record of production from its open pit operations and these will continue for some time yet. But the move underground is designed to secure Tharisa's long-term future, and the company is talking about continuing to mine the reef for 60 years. Phoevos Pourolis, Tharisa's chief executive, joins us to tell us more about the underground development, as well as to talk about sentiment around PGMs and chrome, and the new chrome trading facilities that the company has recently put in place.

Apr 2, 2026 • 12min
2356: Quantum Helium now permitted to production
Quantum Helium has been awarded the operatorship of its Sagebrush asset in Colorado, the last in a line of regulatory hurdles that it had to clear before it was able to initiate major testwork. Accordingly, testing will now get underway shortly after Easter with a view to assessing flow rates, and moving the existing resource, as verified by Sproule, towards a reserve. Quantum Helium's chief executive Howard McLaughlin joins us to fill in the details

Apr 1, 2026 • 1h 17min
2355: 2 P's on a Pod: Small Cap Investing with Paul Hill & Paul Scott
In this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 17 stock ideas.Apologies again for the quality of my video today, albeit the sound was fine. As such we’re going to temporarily pause this weekly show until the technology has been fixed.00:00 Portfolio returns in Q1. Recent buys & sells,03:20 Topps Tiles & building products sector08:25 BRCK/Brickability11:20 Checkit14:05 Fonix18:50 Burford Capital21:35 Airlines & jet fuel costs24:00 hVivo26:45 Spectra Systems29:55 Activeops & software stocks36:05 tinyBuild & gaming companies41:00 Tribal46:15 Keystone Law & possible impact of agentic AI on professional services firms52:25 Plexus58:05 Anpario59:00 Lords Group Trading62:10 Future & other internet real estate assets68:50 Strix71:20 Bioventix

Mar 31, 2026 • 19min
2354: Interview with CEO Jerry Randall and CFO Danny Wells of Venture Life
Following today’s positive and in line Dec’25 results, CEO Jerry Randall and CFO Danny Wells of Venture Life - a leading consumer healthcare products firm - kindly takes me through the:00:00 Key strategic developments over the past year03:20 Drivers underpinning the double digit organic sales growth04:35 Financial highlights06:55 Future M&A strategy09:40 Possible impact from Middle East15:05 May FY’26 outlook & closing remarks

Mar 31, 2026 • 7min
2353: Poolbeg Pharma Secures First Oncology Patent for POLB 001
Poolbeg Pharma announces its first granted patent for POLB 001 in cancer immunotherapy-induced CRS, strengthening its global IP position. The milestone supports future partnering opportunities as the company advances toward key clinical data in 2026.


